Biogen Inc.

NASDAQ: BIIB · Real-Time Price · USD
137.09
2.15 (1.59%)
At close: Aug 15, 2025, 12:47 PM

Biogen Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
1.63B 1.16B 2.96B 1.73B
Depreciation & Amortization
673.2M 494.8M 518.4M 487.7M
Stock-Based Compensation
291.2M 264.2M 254.1M 238.6M
Other Working Capital
-75.6M -648.7M -366.7M -9.1M
Other Non-Cash Items
592.2M 581.2M -1.29B 1.76B
Deferred Income Tax
-158.1M -305.8M -168.6M -426.8M
Change in Working Capital
-155.2M -648.7M -890.3M -145.5M
Operating Cash Flow
2.88B 1.55B 1.38B 3.64B
Capital Expenditures
-359.8M -311.4M -240.3M -258.1M
Cash Acquisitions
-668M -6.14B 990.3M 28.1M
Purchase of Investments
n/a -5.14B -3.45B -3.81B
Sales Maturities Of Investments
144.7M 7.5B 3.67B 3.5B
Other Investing Acitivies
-122.2M -599.7M 607M 12.9M
Investing Cash Flow
-799.2M -4.1B 1.58B -563.7M
Debt Repayment
-650M 187.3M -1B -170M
Common Stock Repurchased
n/a n/a -750M -1.8B
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-33.5M -38M 4.9M -116.2M
Financial Cash Flow
-683.5M 149.3M -1.75B -2.09B
Net Cash Flow
1.33B -2.37B 1.16B 930.2M
Free Cash Flow
2.52B 1.24B 1.14B 3.38B